Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)
Lithium
45.28
0.49%
Gold
2,665.60
0.46%
Copper
4.15
(0.18%)
Oil
68.95
(0.86%)
Bitcoin
97,110.41
2.92%
FTSE 100
8,085.10
(0.17%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
101.80
0.76%
USD/AUD
0.65
0.12%
Hang Seng
19,576.78
(0.35%)

Algorae Pharmaceuticals Ltd

1AI

ASX

Algorae Pharmaceuticals Limited (1AI, formerly Living Cell Technologies Limited) is an Australasian biotechnology company at the forefront of medical innovation. Leveraging cutting-edge research and development, Algorae is dedicated to discovering and developing novel treatments for debilitating conditions such as diabetes and Parkinson's. Their focus extends beyond simply managing these diseases, striving to create transformative solutions that offer a better quality of life for patients.

Latest Posts

Line Chart with Gradient
Price
$0.007
0 (0%)
At Close 20/11 (AEST)
Related Companies
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
$NSB
EPSILON HEALTHCARE LIMITED
$EPN
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
$MVP
VECTUS BIOSYSTEMS LIMITED
$VBS
TRAJAN GROUP HOLDINGS LIMITED
$TRJ

Leave a Comment on 1AI


Comments for 1AI

    Latest Posts

    algorae-pharmaceuticals-asx-1ai-identifies-24-new-drug-targets-1ai
    Health Care $1AI
    Algorae Pharmaceuticals (ASX: $1AI) identifies 24 new drug targetsAI-driven platform AlgoraeOS to enhance drug discovery, focusing on oncology preclinical studies
    November 21, 2024
    algorae-pharmaceuticals-asx-1ai-launches-ai-platform-for-drug-target-predictions-1ai
    Health Care $1AI
    Algorae Pharmaceuticals (ASX: $1AI) launches AI platform for drug target predictionsInnovative technology aims to revolutionize drug development with high prediction accuracy and patent filings
    October 23, 2024
    algorae-pharmaceuticals-asx-1ai-launches-algoraeos-artificial-intelligence-platform-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX: $1AI) launches algoraeos artificial intelligence platform

    Successful launch of AI platform for drug target prediction and validation

    September 24, 2024
    algorae-pharmaceuticals-asx-1ai-to-launch-algoraeos-prediction-platform-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX: $1AI) to launch AlgoraeOS prediction platform

    Ver. 1 AlgoraeOS to predict drug targets using AI and vast scientific data

    July 22, 2024
    algorae-pharmaceuticals-asx-1ai-announces-positive-pre-clinical-neuronal-cell-viability-results-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX: $1AI) announces positive pre-clinical neuronal cell viability results

    AI-116 shows neuroprotective effect exceeding existing FDA registered drug for dementia

    April 8, 2024
    algorae-pharmaceuticals-asx-1ai-develops-ai-biopharmaceutical-prediction-platform-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX: $1AI) develops AI biopharmaceutical prediction platform

    Set to launch AlgoraeOS AI platform in Q3 2024 with Gadi supercomputer support

    March 8, 2024
    algorae-pharmaceuticals-asx-1ai-collaborates-on-pre-clinical-studies-for-ai-168-drug-candidate-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX: $1AI) collaborates on pre-clinical studies for AI-168 drug candidate

    Monash University to conduct pre-clinical studies on cannabinoid-based combination drug

    January 14, 2024
    algorae-pharmaceuticals-asx1ai-collaborates-on-pre-clinical-studies-for-ai-168-drug-candidate-1ai
    Health Care $1AI

    Algorae Pharmaceuticals (ASX:$1AI) collaborates on pre-clinical studies for AI-168 drug candidate

    Monash University to conduct pre-clinical studies on cannabinoid-based combination drug

    November 27, 2023

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) identifies 24 new drug targets

    AI-driven platform AlgoraeOS to enhance drug discovery, focusing on oncology preclinical studies

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) launches AI platform for drug target predictions

    Innovative technology aims to revolutionize drug development with high prediction accuracy and patent filings

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) launches algoraeos artificial intelligence platform

    Successful launch of AI platform for drug target prediction and validation

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) to launch AlgoraeOS prediction platform

    Ver. 1 AlgoraeOS to predict drug targets using AI and vast scientific data

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) announces positive pre-clinical neuronal cell viability results

    AI-116 shows neuroprotective effect exceeding existing FDA registered drug for dementia

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) develops AI biopharmaceutical prediction platform

    Set to launch AlgoraeOS AI platform in Q3 2024 with Gadi supercomputer support

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX: $1AI) collaborates on pre-clinical studies for AI-168 drug candidate

    Monash University to conduct pre-clinical studies on cannabinoid-based combination drug

    1AI

    $1AI

    Algorae Pharmaceuticals (ASX:$1AI) collaborates on pre-clinical studies for AI-168 drug candidate

    Monash University to conduct pre-clinical studies on cannabinoid-based combination drug

    Related Companies
    PROTEOMICS INTERNATIONAL LABORATORIES LTD
    $PIQ
    WELLFULLY LIMITED
    $WFL
    ALTERITY THERAPEUTICS LIMITED
    $ATH
    RACE ONCOLOGY LTD
    $RAC
    PHARMAUST LIMITED
    $PAA

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions